Abstract
Background The long-term impact of coronavirus disease 2019 (COVID-19) on many aspects of society emphasizes the necessity of vaccination and nucleic acid conversion time as markers of prevention and diagnosis. However, little research has been conducted on the immunological effects of vaccines and the influencing factors of virus clearance. Epidemiological characteristics and factors related to disease prognosis and nucleic acid conversion time need to be explored.
Design and participants We reviewed published documentation to create an initial draft. The data were then statistically evaluated to determine their link. Given that a Chongqing shelter hospital is typical in terms of COVID-19 patients receiving hospital management and treatment effects, a retrospective analysis was conducted on 4,557 cases of COVID-19 infection in a shelter hospital in Chongqing in December 2022, which comprised 2,291 males and 2,266 females. The variables included age, medical history, nucleic acid conversion time, vaccination status, and clinical symptoms.
Results Univariate survival analysis using the Log-rank test (P < 0.05) showed that factors such as age significantly affected nucleic acid conversion time. COX regression analysis indicated a significant association between a history of hypertension and nucleic acid conversion time, which had a hazard ratio of 0.897 (95% CI: 0.811–0.992). A statistically significant difference was observed between vaccinated and unvaccinated infected individuals in terms of the presence of symptoms such as cough and sensory system manifestations (P < 0.05).
Conclusion The effect of vaccination against COVID-19 on symptoms such as coughing, nasal congestion, muscle aches, runny nose, and sensory system symptoms in COVID-19 patients was determined. Typical symptoms, such as runny nose, were generally higher in vaccinated than in unvaccinated ones; previous hypertension was an influential factor in nucleic acid conversion time in patients with COVID-19 infection.
STRENGTHS AND LIMITATIONS This study clarifies the advantages of vaccination by comparing the symptom development between patients who had received vaccinations and those who had not.
This research suggests potential future study directions, such as investigating the impact of pre-existing diseases like hypertension on viral clearance time and assessing vaccine efficacy and safety in certain demographic groups.
This work investigated data from 4,557 coronavirus disease 2019 patients admitted to a shelter hospital, which offered significant insights into patients’ clinical features and outcomes over a defined time span.
This study has several flaws because a retrospective analysis method was used and not all confounding variables that might have affected the results were appropriately controlled.
The overall research sample may not be representative of other communities because it was drawn from a shelter hospital in Chongqing, and the types of immunizations used were not disclosed. These factors might have had an impact on the precision and extent of the research findings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Program for Emergency Special Scientific Research Project of Chongqing Health Commission Grant for Efficacy Evaluation of Traditional Chinese Medicine in Novel Coronavirus Infection (2023NCPZX04) and Scientific and Technological Research Program of Chongqing Municipal Education Commission (KJZD-K202215103).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Chongqing medical university's ethics committee gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data generated in this study are available to the authors upon reasonable request.
